Substance / Medication

Egg phospholipid

Overview

Active Ingredient
egg yolk phospholipids
RxNorm CUI
314605

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Maternal asthma during pregnancy and risks of allergy and asthma in progeny: A systematic review and meta-analysis.
Roff Andrea J, Robinson Joshua L, Hammond Sarah J et al. · BJOG · 2025
PMID: 38973390Meta-AnalysisFull text (PMC)
Causal Effects of Asthma on Upper Airway Diseases and Allergic Diseases: A Two-Sample Mendelian Randomization.
Zhang Zengxiao, Li Gongfei, Zhou Shizhe et al. · Int Arch Allergy Immunol · 2025
PMID: 39106836Meta-Analysis
Association between allergic diseases and mental health conditions: An umbrella review.
Xu Xianpeng, Li Sha, Chen Yingjie et al. · J Allergy Clin Immunol · 2025
PMID: 39521284Meta-Analysis
A genome-wide meta-analysis reveals shared and population-specific variants for allergic sensitization.
Noguchi Emiko, Morii Wataru, Kitazawa Haruna et al. · J Allergy Clin Immunol · 2025
PMID: 39644933Meta-Analysis
Docosahexaenoic acid-enriched egg phospholipids supplementation induces accretion of arachidonic acid in rat blood lipids.
Gleize B, Payet M, Esmail M H et al. · Cell Mol Biol (Noisy-le-grand) · 2004
PMID: 15672471Observational
Egg phospholipids and cardiovascular health.
Blesso Christopher N · Nutrients · 2015
PMID: 25871489ReviewFull text (PMC)
Egg phospholipids exert an inhibitory effect on intestinal cholesterol absorption in mice.
Lee Yoojin, Han Catherine Y, Bae Minkyung et al. · Nutr Res Pract · 2019
PMID: 31388405OtherFull text (PMC)
The partitioning of PAHs to egg phospholipids facilitated by copper and proton binding via cation-pi interactions.
Qu Xiaolei, Wang Xiaorong, Zhu Dongqiang · Environ Sci Technol · 2007
PMID: 18200858Other

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Egg phospholipid (substance)
SNOMED CT
713383006
UMLS CUI
C0982134
RxNorm CUI
314605

Clinical Data

This intervention maps to 1 entities in the Healos knowledge graph.

1
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.